Irritable bowel syndrome (IBS) affects 5–10% of the global population. Up to one-third of
people with IBS also experience anxiety or depression. Gastrointestinal and psychological …

The human gut microbiome contains the largest number of bacteria in the body and has the
potential to greatly influence metabolism, not only locally but also systemically. There is an …

Irritable bowel syndrome (IBS) is a chronic functional gastrointestinal disorder characterized
by abdominal pain associated with defecation or a change in bowel habits. The …

The low FODMAP (fermentable oligosaccharide, disaccharide, monosaccharide, and polyol)
diet is a beneficial therapeutic approach for patients with irritable bowel syndrome (IBS) …

Irritable Bowel Syndrome (IBS) is a chronic, recurrent functional disorder of the intestine
diagnosed based on the Rome IV criteria. Individuals suffering from IBS often associate the …

Most adverse reactions to food are patient self-reported and not based on validated tests but
nevertheless lead to dietary restrictions, with patients believing that these restrictions will …

Background Gut‐directed hypnotherapy (GDH) has high rates of durable efficacy for treating
irritable bowel syndrome (IBS) but its widespread use is limited due to high costs and poor …

A diet low in fermentable oligosaccharides, disaccharides, monosaccharides and polyols
(FODMAP) improves functional bowel symptoms and is a second-line dietary management …

This review summarizes current knowledge on the role of low-FODMAP diet and gluten-free
diet in functional abdominal bloating and distension, an emerging disorder of gut-brain …

Symptoms of the disorders across the irritable bowel syndrome (IBS) spectrum include
several different, usually postprandial, abdominal complaints. Up to date, dietary treatments …